Jan Astermark

8.3k citations
183 papers · 6.7k · 1 hit paper · h-index 44

Impact in

  • Hematology top 0.1%
    • Hemophilia Treatment and Research
    • Platelet Disorders and Treatments
    • Blood Coagulation and Thrombosis Mechanisms
    • Hemostasis and retained surgical items
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.5%
    • Coagulation, Bradykinin, Polyphosphates, and Angioedema
    • Virus-based gene therapy research

Papers in

    • Hemophilia Treatment and Research 161
    • Platelet Disorders and Treatments 40
    • Blood Coagulation and Thrombosis Mechanisms 36
    • Chronic Myeloid Leukemia Treatments 19
    • Hemostasis and retained surgical items 7
    • Coagulation, Bradykinin, Polyphosphates, and Angioedema 24
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 13

Jan Astermark

176 papers receiving 6.5k citations

Jan Astermark's Hit Papers

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B 2023 · 260 citations
2600+1+2Years since publication50100150200250

Peers

Jan Astermark
Comparison fields: 5 of 100
  • Hematology 6.0k
  • Genetics 1.3k
  • Internal Medicine 76
  • Molecular Biology 1.1k
  • Genetics 319
Replace Maria Elisa Mancuso with:
Maria Elisa Mancuso Italy
Jerzy Windyga Poland
Rebecca Kruse‐Jarres United States
Jason Tay Canada
Mark P. Smith New Zealand
Aline Schmidt France
Quentin A. Hill United Kingdom
Heesun Joyce Rogers United States
Deborah Hurst United States
Urs Hess Switzerland
Jan Astermark relative to Maria Elisa Mancuso Italy Maria Elisa Mancuso's profile →
Citations per field
00.5×1.7×
Maria Elisa Mancuso · 1×
Citations per year

Countries citing papers authored by Jan Astermark

Since Specialization
Citations

This map shows the geographic impact of Jan Astermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Astermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Astermark more than expected).

Fields of papers citing papers by Jan Astermark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Astermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Astermark. The network helps show where Jan Astermark may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan Astermark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Astermark Line = papers co-authored together Jan Astermark links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2006369
2 2012290
3 2008279
4
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
Hit paper breakdown →
2023260
5 1999235
6 2003229
7 2005217
8 2013183
9 2008179
10 2006173
11 2001172
12 2009148
13 2007132
14 2003125
15 2019125
16 2009122
17 2010111
18 2003104
19 2003100
20 200694

About Jan Astermark

Jan Astermark is a scholar working on Hematology, Genetics, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Internal Medicine, having authored 183 papers that have together received 6.7k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (161 papers), Platelet Disorders and Treatments (40 papers), Blood Coagulation and Thrombosis Mechanisms (36 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (24 papers), Cancer-related gene regulation (22 papers), Chronic Myeloid Leukemia Treatments (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers) and Hemostasis and retained surgical items (7 papers). The work is most often cited by research in Hematology (6.0k citations), Genetics (1.3k citations), Internal Medicine (76 citations), Molecular Biology (1.1k citations) and Genetics (319 citations). Jan Astermark has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Erik E. Berntorp, Johannes Oldenburg, Erik E. Berntorp, A. Gringeri, Sharyne M Donfield, Rolf C. R. Ljung, Donna DiMichele, Kathelijn Fischer, Sam Schulman and Steven A. Gilbert. Their work appears in journals such as Haemophilia, Blood, Journal of Thrombosis and Haemostasis, Thrombosis Research and European Journal Of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact